Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion
The deal adds navtemadlin—a drug candidate for a rare blood cancer in late-stage clinical trials—to Ipsen’s oncology pipeline.
Connecting Global Economies
Flash News
Wimbledon 2026 live updates: Day 1 latest with Djokovic, Sabalenka and Sinner in action today
Critical rescue window passes in quake-hit Venezuela as death toll nears 1,500
Why Isn’t Carlos Alcaraz at Wimbledon 2026: Wrist Injury, Recovery
Is this World Cup now Europe v South America? Which giants fall today? Day 18 recap
Paris mortuaries overwhelmed as Europe’s record heat drives up death toll
Janet Jackson Surprise Arrival Makes Teyana Taylor Cry
Manchester United’s greatest players: No 23: Bill Foulkes
Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion
Nasa turns to robotic spacecraft to save telescope from falling back to Earth
AI data centers face heatwave and severe weather climate risks
Monday, June 29, 2026